Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 19, Issue 1, Pages 89-98
Publisher
Oxford University Press (OUP)
Online
2016-09-01
DOI
10.1093/neuonc/now187
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The benefit of surgical resection in recurrent glioblastoma
- (2016) Michael A. Vogelbaum NEURO-ONCOLOGY
- Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma
- (2016) Sina Burth et al. NEURO-ONCOLOGY
- Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial
- (2016) Bogdana Suchorska et al. NEURO-ONCOLOGY
- Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: A multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma
- (2015) BENJAMIN M. ELLINGSON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity
- (2014) Mark E. Oppenlander et al. JOURNAL OF NEUROSURGERY
- Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma
- (2014) Matthew M. Grabowski et al. JOURNAL OF NEUROSURGERY
- Reoperation for Recurrent High-Grade Glioma
- (2014) Shawn L. Hervey-Jumper et al. NEUROSURGERY
- Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma
- (2013) B. M. Ellingson et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Recurrent glioblastoma: Volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab
- (2013) Raymond Y. Huang et al. CANCER
- Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial
- (2013) Benjamin M. Ellingson et al. RADIOLOGY
- Impact of extent of resection for recurrent glioblastoma on overall survival
- (2012) Orin Bloch et al. JOURNAL OF NEUROSURGERY
- Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging
- (2012) R. F. Barajas et al. NEURO-ONCOLOGY
- Does Extent of Resection of a Glioblastoma Matter?
- (2012) Michael A. Vogelbaum NEUROSURGERY
- An extent of resection threshold for newly diagnosed glioblastomas
- (2011) Nader Sanai et al. JOURNAL OF NEUROSURGERY
- Independent association of extent of resection with survival in patients with malignant brain astrocytoma
- (2008) Matthew J. McGirt et al. JOURNAL OF NEUROSURGERY
- GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
- (2008) Nader Sanai et al. NEUROSURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started